3-37025608-ATTTTTTTTT-ATTTTTTTTTTTT
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000249.4(MLH1):c.1039-10_1039-8dupTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0018 ( 2 hom., cov: 0)
Exomes 𝑓: 0.0010 ( 5 hom. )
Consequence
MLH1
NM_000249.4 splice_region, intron
NM_000249.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0340
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 3-37025608-A-ATTT is Benign according to our data. Variant chr3-37025608-A-ATTT is described in ClinVar as [Likely_benign]. Clinvar id is 413377.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00184 (89/48272) while in subpopulation EAS AF= 0.00484 (10/2064). AF 95% confidence interval is 0.00375. There are 2 homozygotes in gnomad4. There are 38 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00184 AC: 89AN: 48284Hom.: 2 Cov.: 0
GnomAD3 genomes
AF:
AC:
89
AN:
48284
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00158 AC: 22AN: 13956Hom.: 5 AF XY: 0.00119 AC XY: 10AN XY: 8400
GnomAD3 exomes
AF:
AC:
22
AN:
13956
Hom.:
AF XY:
AC XY:
10
AN XY:
8400
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00101 AC: 260AN: 257918Hom.: 5 Cov.: 0 AF XY: 0.000937 AC XY: 120AN XY: 128044
GnomAD4 exome
AF:
AC:
260
AN:
257918
Hom.:
Cov.:
0
AF XY:
AC XY:
120
AN XY:
128044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00184 AC: 89AN: 48272Hom.: 2 Cov.: 0 AF XY: 0.00177 AC XY: 38AN XY: 21492
GnomAD4 genome
AF:
AC:
89
AN:
48272
Hom.:
Cov.:
0
AF XY:
AC XY:
38
AN XY:
21492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Apr 18, 2017
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Breast and/or ovarian cancer Benign:1
Oct 28, 2022
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
MLH1: BP4, BS2 -
Hereditary nonpolyposis colorectal neoplasms Benign:1
Apr 15, 2016
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
La Branchor
BranchPoint Hunter
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at